Skip Ribbon Commands
Skip to main content
Navigate Up
Sign In

Quick Launch

MARK REISMAN, MD

 

Section Head, Interventional Cardiology
Director, Structural Heart Services, Regional Heart Center
Clinical Professor of Medicine
University of Washington Medical Center

 

University of Washington

1959 Pacific Street

Seattle, WA. 98195-6424

 

 

 

EDUCATION AND TRAINING

  • BS, Biochemistry, State University of New York at Stonybrook, 1980
  • MD, Sackler Schoole of Medicine, New York Program, 1985

 

BOARD CERTIFICATION

  • American Board of Internal Medicine, Internal Medicine, 1988
  • Diplomat, American Board of Internal Medicine, Subspecialty Cardiovascular Disease, 1991 (re-certified May 2013)
  • American Board of Interternal Medicine, Interventional Cardiology, 1999 (updated 2011)

 

AREAS OF CLINICAL EXPERTISE

  • Cardiocascular Emerging Therapies
  • Coronary Artery Disease
  • Structural Heart Disease

 

SPECIAL ACCOMPLISHMENTS

  • Director of Cardiovascular Emerging Therapies
  • President of the Board of Directors for the Seattle Science Foundation 
  • Transcatheter Valvue Therapies (TVT), Cardiovascular Research Foundation, Co-Director 
 

 Selected Publications

 
 
Elmariah S, Furlan AJ, Reisman M, et al. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients with a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial. JAm Coll Cardiol Intv. 2014 Aug; 7(8):913-920. PMID: 25147037
 
 
Vakil K, Roukoz H, Sarraf M, Krishnan B, Reisman M, Levy WC, Adabag S. Safety and efficacy of the MitraClip® system for severe mitral regurgitation: a systematic review. Catheter Cardiovasc Interv. 2014 Jul 1;84(1):129-36. doi: 10.1002/ccd.25347. Epub 2014 Jan 7. PMID: 24323764
 
 
 
Don CW, Kim MS, Verrier ED, Aldea GS, Dean LS, Reisman M, Mokadam NA. Novel use of an apical-femoral wire rail to assist with transfemoral transcatheter aortic valve replacement. J Invasive Cardiol. 2014 Jun;26(6):E63-5.PMID: 24907088
 
 
 
Wessler BS, Thaler DE, Ruthazer R, Weimar C, Di Tullio MR, Elkind MS, Homma S, Lutz JS, Mas JL, Mattle HP, Meier B, Nedeltchev K, Papetti F, Di Angelantonio E, Reisman M, Serena J, Kent DM. Response to letter regarding article, "Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale analysis of putative high-risk features from the risk of paradoxical embolism database". Circ Cardiovasc Imaging. 2014 May;7(3):573. doi: 10.1161/CIRCIMAGING.114.001756. PMID: 24847015
 
 
 
Don CW, Fuller CJ, Reisman M. Transcatheter left atrial appendage occlusion. Cardiol Clin. 2013 Aug;31(3):363-84. doi: 10.1016/j.ccl.2013.05.008. Review. PMID: 23931100
 
 
 
Makkar RR, Jilaihawi H, Chakravarty T, Fontana GP, Kapadia S, Babaliaros V, Cheng W, Thourani VH, Bavaria J, Svensson L, Kodali S, Shiota T, Siegel R, Tuzcu EM, Xu K, Hahn RT, Herrmann HC, Reisman M, Whisenant B, Lim S, Beohar N, Mack M, Teirstein P, Rihal C, Douglas PS, Blackstone E, Pichard A, Webb JG, Leon MB. Determinants and outcomes of acute transcatheter valve-in-valve therapy or embolization: a study of multiple valve implants in the U.S. PARTNER trial (Placement of AoRTic TraNscathetER Valve Trial Edwards SAPIEN Transcatheter Heart Valve). J Am Coll Cardiol. 2013 Jul 30;62(5):418-30. doi: 10.1016/j.jacc.2013.04.037. Epub 2013 May 15. PMID: 23684680